Top1000 Scholar

Scholarly Index

Dawn L. Hershman

Columbia University; 41,192 total citations; 1,073 total publications; best world rank #12

Columbia University

41,192Total citations
1,073Total publications
102H-index

Published ranking records

FieldWindowWorld rankNational rankImpact score
Medical and Health Sciences2021-2025808US 28299.82
Economics and Finance2021-2025674US 18197.36
OncologyLifetime152US 8199.75
Obstetrics and GynecologyLifetime260US 11998.25
Cancer ResearchLifetime490US 25596.94
Family PracticeLifetime55US 3296.84
Reproductive MedicineLifetime398US 19697.30
Oncology2021-2025161US 7298.77
Econometrics and Quantitative Economics2021-2025481US 10597.34
Public, Environmental and Occupational Health2021-2025513US 19595.03
Reproductive Medicine2021-2025206US 6290.21
Pulmonary and Respiratory Medicine2021-2025754US 27590.38
Family Practice2021-202536US 1187.80
Cancer Research2021-2025247US 8886.45
Obstetrics and Gynecology2021-2025258US 8788.57
Pediatrics, Perinatology and Child Health2021-2025521US 21086.16
Economic and Financial Impacts of CancerLifetime12US 1099.72
Cancer Treatment and PharmacologyLifetime77US 4399.72
COVID-19 and healthcare impactsLifetime53US 1998.61
Global Cancer Incidence and ScreeningLifetime81US 4599.32
Medication Adherence and ComplianceLifetime33US 2699.09
Chemotherapy-related skin toxicityLifetime20US 1198.86
Cancer survivorship and careLifetime107US 6199.02
Breast Cancer Treatment StudiesLifetime220US 11399.27
Endometrial and Cervical Cancer TreatmentsLifetime144US 7999.12
Health Systems, Economic Evaluations, Quality of LifeLifetime380US 18598.95
Chemotherapy-induced cardiotoxicity and mitigationLifetime57US 3598.45
Ovarian cancer diagnosis and treatmentLifetime273US 14498.72
BRCA gene mutations in cancerLifetime209US 11798.30
Intraperitoneal and Appendiceal MalignanciesLifetime125US 5998.21
Uterine Myomas and TreatmentsLifetime222US 8698.26
Cancer Risks and FactorsLifetime226US 11498.35
Neutropenia and Cancer InfectionsLifetime232US 11497.83
Cancer-related cognitive impairment studiesLifetime118US 8496.97
HER2/EGFR in Cancer ResearchLifetime633US 28697.42
Advanced Breast Cancer TherapiesLifetime318US 14697.41
Multiple Myeloma Research and TreatmentsLifetime728US 32596.54
Multiple and Secondary Primary CancersLifetime480US 21395.48
Endometriosis Research and TreatmentLifetime975US 29495.72
Blood disorders and treatmentsLifetime573US 23394.12
Ethics in Clinical ResearchLifetime459US 25893.70
Complementary and Alternative Medicine StudiesLifetime814US 29490.95
Statistical Methods in Clinical TrialsLifetime942US 49391.51
Economic and Financial Impacts of Cancer2021-202519US 1398.91
COVID-19 and healthcare impacts2021-2025182US 6196.27
Global Cancer Incidence and Screening2021-2025137US 5497.02
Cancer survivorship and care2021-2025170US 6996.17
Cancer Treatment and Pharmacology2021-2025217US 7495.66
Metabolism, Diabetes, and Cancer2021-2025194US 5893.86
Medication Adherence and Compliance2021-2025112US 4691.96
Breast Cancer Treatment Studies2021-2025474US 15894.94
Health Systems, Economic Evaluations, Quality of Life2021-2025920US 29993.30
Advanced Breast Cancer Therapies2021-2025294US 10894.74
Palliative Care and End-of-Life Issues2021-2025574US 21792.84
HER2/EGFR in Cancer Research2021-2025533US 19191.32
Childhood Cancer Survivors' Quality of Life2021-2025903US 41288.78
Uterine Myomas and Treatments2021-2025528US 10486.40
Cancer Risks and Factors2021-2025453US 16383.85
Neutropenia and Cancer Infections2021-2025366US 13281.05
Multiple and Secondary Primary Cancers2021-2025429US 15378.58
Pain Management and Opioid Use2021-2025467US 25580.66
Healthcare cost, quality, practices2021-2025553US 23277.75
Chemotherapy-induced cardiotoxicity and mitigation2021-2025500US 14378.01
Cancer-related cognitive impairment studies2021-2025849US 31567.22
Gynecological conditions and treatments2021-2025738US 10965.69